Minimizing risk while promoting compliance, Ansur v3.0 standardizes work and reduces test time to increase productivity and reduce errors in medical device QA testing. Customizable user, author, and administrator authorization levels enhance traceability and manageability, and users can create FDA 21 CFR Part 11-compliant signature to sign templates and results. Customizable DUT fields let users specify number of fields, groups of fields, and field names when creating/modifying Ansur templates.